[go: up one dir, main page]

CH510620A - Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten - Google Patents

Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten

Info

Publication number
CH510620A
CH510620A CH422069A CH422069A CH510620A CH 510620 A CH510620 A CH 510620A CH 422069 A CH422069 A CH 422069A CH 422069 A CH422069 A CH 422069A CH 510620 A CH510620 A CH 510620A
Authority
CH
Switzerland
Prior art keywords
antihypertensive
new
production
hydroxylamine derivatives
hydroxylamine
Prior art date
Application number
CH422069A
Other languages
English (en)
Inventor
Lajos Dr Kisfaludy
Dancsi Lajos
Patthy Agnes
Laszolo Dr Szporny
Livia Dr Domok
Egon Dr Karpati
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to CH634171A priority Critical patent/CH515878A/de
Publication of CH510620A publication Critical patent/CH510620A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
CH422069A 1968-03-30 1969-03-20 Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten CH510620A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH634171A CH515878A (de) 1968-03-30 1969-03-20 Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000343 1968-03-30

Publications (1)

Publication Number Publication Date
CH510620A true CH510620A (de) 1971-07-31

Family

ID=11000825

Family Applications (1)

Application Number Title Priority Date Filing Date
CH422069A CH510620A (de) 1968-03-30 1969-03-20 Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten

Country Status (10)

Country Link
US (1) US3642805A (de)
JP (1) JPS4843726B1 (de)
AT (2) AT296252B (de)
CH (1) CH510620A (de)
DE (1) DE1916481C3 (de)
DK (1) DK126426B (de)
FR (1) FR2007354B1 (de)
GB (1) GB1240224A (de)
NL (1) NL6904889A (de)
SE (1) SE375760B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322987A (en) * 1969-12-29 1973-07-11 Richter Gedeon Vegyeszet On,n-diacylhydroxylamine derivatives and preparation
US4028401A (en) * 1976-07-01 1977-06-07 Morton-Norwich Products, Inc. (Substituted)ureidoacetohydroxamic acids
US4496541A (en) * 1983-01-12 1985-01-29 Usv Pharmaceutical Corporation Compounds for treating hypertension
JPS6321067U (de) * 1986-07-26 1988-02-12
US5228899A (en) * 1989-08-25 1993-07-20 Sumitomo Chemical Company Limited Hydroxamic acid esters and plant growth regulation therewith
US5254724A (en) * 1991-10-30 1993-10-19 University Of Florida Research Foundation, Inc. Method for synthesis of desferrioxamine B, analogs and homologs thereof
DE10007308A1 (de) * 2000-02-17 2001-08-23 Bosch Gmbh Robert Verfahren und Vorrichtung zur Ermittlung der verbleibenden Betriebsdauer eines Produktes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1167934A (fr) * 1955-06-28 1958-12-03 Hoffmann La Roche Procédé pour la préparation de nouveaux dérivés d'alpha-amino-beta-hydroxy-acides

Also Published As

Publication number Publication date
JPS4843726B1 (de) 1973-12-20
US3642805A (en) 1972-02-15
DE1916481A1 (de) 1969-10-09
GB1240224A (en) 1971-07-21
DE1916481C3 (de) 1974-06-27
FR2007354B1 (de) 1974-01-11
DK126426B (da) 1973-07-16
NL6904889A (de) 1969-10-02
DE1916481B2 (de) 1973-11-29
AT296252B (de) 1972-02-10
FR2007354A1 (de) 1970-01-09
AT293358B (de) 1971-10-11
SE375760B (de) 1975-04-28

Similar Documents

Publication Publication Date Title
AT298451B (de) Verfahren zur Herstellung von neuen, basisch substituierten Phenolen
CH529774A (de) Verfahren zur Herstellung von neuen Isoxazolderivaten
CH548412A (de) Verfahren zur herstellung von neuen 5-nitrofurylderivaten.
CH558342A (de) Verfahren zur herstellung von neuen phenolderivaten.
AT269855B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten
CH510668A (de) Verfahren zur Herstellung von neuen 1,6-Dimethyl-10a-ergolinderivaten
CH547793A (de) Verfahren zur herstellung von neuen evomonosid-derivaten.
CH510620A (de) Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten
CH547820A (de) Verfahren zur herstellung von neuen 5-nitrofurylderivaten.
AT309457B (de) Verfahren zur Herstellung von neuen Nitrofuranderivaten
AT322117B (de) Verfahren zur herstellung von neuen, heterocyclisch substituierten nebularin-derivate
CH525893A (de) Verfahren zur Herstellung von neuen Benzomorphanderivaten
CH513147A (de) Verfahren zur Herstellung von neuen Benzofuranderivaten
AT290522B (de) Verfahren zur Herstellung von neuen Cumarinderivaten
AT281816B (de) Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate
CH518941A (de) Verfahren zur Herstellung von neuen 3,5-Dioxopyrazolidinderivaten
AT281863B (de) Verfahren zur Herstellung von neuen Hydantoinderivaten
AT295144B (de) Verfahren zur Herstellung von neuen, überwiegend linearen Polybiureten
CH546787A (de) Verfahren zur herstellung von neuen 5-nitrofurylderivaten.
AT297949B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
AT303982B (de) Verfahren zur Herstellung von neuen 7α-Methyl-1α,2α-methylen-androstenolonen
AT305267B (de) Verfahren zur Herstellung von neuen 11-Aminoalkyl-9,10-ätheno-anthracenen
AT291280B (de) Verfahren zur Herstellung von neuen Harnstoffderivaten
AT291278B (de) Verfahren zur Herstellung von neuen Harnstoffderivaten
CH554310A (de) Verfahren zur herstellung von neuen 1-aminoalkylidenbenzcycloalkan-2-spirocycloaliphatischen verbindungen.

Legal Events

Date Code Title Description
PL Patent ceased